Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease_West China Medical Journal

Authors：

REN Qiang , ZHENG Yongchi

Department of Pharmacy, People′s Hospital of Dujiangyan, Chengdu, Sichuan 611830, P. R. China;

Corresponding?author：

Keywords：

慢性阻塞性肺疾病; 藥學監護; 臨床藥師

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

【摘要】　目的　探討慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）治療方案及藥學監護的內容。　方法　以2007年12月收治的1例COPD患者為例，結合COPD治療指南，為COPD急性加重期患者制定個體化的藥學監護計劃并實施全程的藥學監護。　結果　患者COPD急性加重期的藥物治療方案有效合理。通過全程的藥學監護，及時發現和解決了患者藥物治療的問題，為臨床合理用藥提供了意見。　結論　對COPD患者實施藥學監護具有可行性和實用性。
【Abstract】　Objective　 To investigate the treatment and pharmaceutical care for chronic obstructive pulmonary disease (COPD) patients.　Methods　 In December 2007, a patient with COPD was diagnosed, and based on the clinical data, COPD treatment guidelines were adopted to analyze treatment plans. For patients with acute exacerbation of COPD, individualized pharmaceutical care plan was proposed, and pharmaceutical care was performed during the whole course of disease.　Results　 The drug treatment for the one patient with acute exacerbation of COPD was effective and reasonable. Treatment problems were observed and solved through pharmaceutical care which had given reasonable suggestions for medication.　Conclusion　 The implementation of pharmaceutical care for COPD patients is feasible and practical.

Citation： REN Qiang,ZHENG Yongchi. Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease. West China Medical Journal, 2011, 26(12): 1853-1855. doi: Copy

1.	中華醫學會呼吸病學分會慢性阻塞性肺疾病學組. COPD診治指南2007年修訂版[J]. 繼續教育, 2007, 21(2): 31-42.
2.	Sethi S, Murphy TF. Infection in the pathogenesis and course ofchronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22): 2355-2365.
3.	周慶濤, 賀蓓. 慢性阻塞性肺疾病急性加重期的抗菌藥物應用——COPD指南解讀[J]. 中國藥物應用與監測, 2011, 8(2): 65-68.
4.	Seemungal TAR, Wilkinson TMA, Hurst JR, et al. Long-termerythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations[J]. Am J Respir Crit Care Med, 2008, 178(11): 1139-1147.
5.	Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mile and moderate chronic obstructive pulmonary disease:a randomized controlled trial[J]. Lancet, 1999, 353(9167): 1819-1823.
6.	Luncel Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease[J]. N Engl J Med, 1999, 343(26): 1902-1909.
7.	葉曉芬, 蔡映云, 呂遷洲. 臨床藥師對住院病人如何開展藥學監護[J]. 中國執業藥師, 2009, 2(6): 8-10.

1. 　中華醫學會呼吸病學分會慢性阻塞性肺疾病學組. COPD診治指南2007年修訂版[J]. 繼續教育, 2007, 21(2): 31-42.
2. 　Sethi S, Murphy TF. Infection in the pathogenesis and course ofchronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22): 2355-2365.
3. 　周慶濤, 賀蓓. 慢性阻塞性肺疾病急性加重期的抗菌藥物應用——COPD指南解讀[J]. 中國藥物應用與監測, 2011, 8(2): 65-68.
4. 　Seemungal TAR, Wilkinson TMA, Hurst JR, et al. Long-termerythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations[J]. Am J Respir Crit Care Med, 2008, 178(11): 1139-1147.
5. 　Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mile and moderate chronic obstructive pulmonary disease:a randomized controlled trial[J]. Lancet, 1999, 353(9167): 1819-1823.
6. 　Luncel Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease[J]. N Engl J Med, 1999, 343(26): 1902-1909.
7. 　葉曉芬, 蔡映云, 呂遷洲. 臨床藥師對住院病人如何開展藥學監護[J]. 中國執業藥師, 2009, 2(6): 8-10.

West China Medical Journal

Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease

Abstract Full text Figures/Tables Video References Cited by

Format

Content